This compound is a deuterated pharmaceutical reference standard used in analytical testing and quality control. It is a structural analogue of a pharmacologically active molecule, featuring multiple deuterium substitutions.
Content scope: Information here supports chemical identification and industrial supply, research, and manufacturing contexts. It is not a therapeutic claim, medical advice, or drug-use instructions.
Sourcing or supplying this compound?
List your inventory or post a purchase request
CAS 1089736-73-1
N-(1-oxopentyl)-N-((2'-(2H-tetrazol-5-yl)(1,1'-biphenyl)-4-yl)methyl)-L-valine methyl ester
pharmaceutical raw material
Phenyl (3R,4R)-4-(3-isopropoxyphenyl)-3,4-dimethylpiperidine-1-carboxylate
pharmaceutical raw material
Octreotide Impurity 13
pharmaceutical raw material
Alogliptin Impurity 14
pharmaceutical raw material
Pyrimidin-2-amine
pharmaceutical raw material
Poziotinib
pharmaceutical raw material
(²H₃)Methyl [(5S,10S,11S,14S)-11-benzyl-5-tert-butyl-10-hydroxy-15,15-dimethyl-3,6,13-trioxo-8-{[4-(pyridin-2-yl)phenyl]methyl}(1,1,1-²H₃)-2-oxa-4,7,8,12-tetraazahexadecan-14-yl]carbamate (non-preferred name)
pharmaceutical raw material
(3S,4S)-4-Methyl-3-(methyl-7H-pyrrolo[2,3-d]pyrimidin-4-ylamino)-beta-oxo-1-piperidinepropanenitrile
pharmaceutical raw material
(2S)-3-methyl-2-[2,2,3,3,4,4,5,5,5-nonadeuteriopentanoyl-[[4-[2-(2H-tetrazol-5-yl)phenyl]phenyl]methyl]amino]butanoic acid
ACWBQPMHZXGDFX-KDDXQTGLSA-N
[2H]C([2H])([2H])C([2H])([2H])C([2H])([2H])C([2H])([2H])C(=O)N(CC1=CC=C(C=C1)C2=CC=CC=C2C3=NNN=N3)[C@@H](C(C)C)C(=O)O